NCT02692391View on ClinicalTrials.gov

A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 19, 2019

Study Completion Date

December 30, 2019

Conditions
Acute Pancreatitis
Interventions
DRUG

Indomethacin

Rectal indomethacin will be administered as 100 mg loading doses following by 5 maintenance doses of 50 mg at internals of 8 hours for total of 48 hours.

DRUG

Placebo

Glycerin placebo suppositories which are identical in shape, size, color, and packaging to rectal indomethacin

Trial Locations (1)

15213

Univeristy of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT02692391 - A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis | Biotech Hunter | Biotech Hunter